Robert C. Welliver

Robert C. Welliver publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Robert C. Welliver sits on this spectrum.

Robert C. Welliver D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert C. Welliver sits on this spectrum.

Overview

Best Publications

• The Development of Respiratory Syncytial Virus-Specific IgE and the Release of Histamine in Nasopharyngeal Secretions after Infection

  Robert C. Welliver;David T. Wong;Martha Sun;Elliott Middleton

  739
  Citations

• Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children

  Unknown

  702
  Citations

• Vaccination Strategies for Mucosal Immune Responses

  Pearay L. Ogra;Howard Faden;Robert C. Welliver

  583
  Citations

• Severe Human Lower Respiratory Tract Illness Caused by Respiratory Syncytial Virus and Influenza Virus Is Characterized by the Absence of Pulmonary Cytotoxic Lymphocyte Responses

  Timothy P. Welliver;Roberto P. Garofalo;Yashoda Hosakote;Karen H. Hintz

  486
  Citations

• Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection.

  Robert C Welliver

  474
  Citations

• Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection.

  Roberto Garofalo;Jan L.L. Kimpen;Jan L.L. Kimpen;Robert C. Welliver;Robert C. Welliver;Pearay L. Ogra

  378
  Citations

• Increased production of IFN-γ and cysteinyl leukotrienes in virus-induced wheezing

  Sandrijn M. van Schaik;Debra A. Tristram;Inderjeet S. Nagpal;Karen M. Hintz

  327
  Citations

• The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus

  S. Yusuf;G. Piedimonte;A. Auais;G. Demmler

  300
  Citations

• Macrophage Inflammatory Protein-1α (Not T Helper Type 2 Cytokines) Is Associated with Severe Forms of Respiratory Syncytial Virus Bronchiolitis

  Roberto P. Garofalo;John Patti;Karen A. Hintz;Vanessa Hill

  293
  Citations

• Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis

  Robert C. Welliver;Robert C. Welliver;Martha Sun;Martha Sun;Deborah Rinaldo;Deborah Rinaldo;Pearay L. Ogra;Pearay L. Ogra

  275
  Citations

• The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease.

  B Volovitz;R C Welliver;R C Welliver;G De Castro;G De Castro;D A Krystofik;D A Krystofik

  274
  Citations

• The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection.

  Robert C. Welliver;Tej N. Kaul;Pearay L. Ogra

  239
  Citations

• The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years.

  Robert C. Welliver;Linda Duffy

  229
  Citations

• The antibody response to primary and secondary infection with respiratory syncytial virus: Kinetics of class-specific responses*

  Robert C. Welliver;Robert C. Welliver;Tej N. Kaul;Tej N. Kaul;Theodore I. Putnam;Theodore I. Putnam;Martha Sun;Martha Sun

  203
  Citations

• Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease

  Eric A.F. Simoes;Henry M. Sondheimer;Franklin H. Top;H.Cody Meissner

  196
  Citations

• Respiratory Syncytial Virus (RSV) Immune Globulin Intravenous Therapy for RSV Lower Respiratory Tract Infection in Infants and Young Children at High Risk for Severe RSV Infections

  W. J. Rodriguez;W. C. Gruber;R. C. Welliver;J. R. Groothuis

  192
  Citations

• Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection.

  Robert C. Welliver;David T. Wong;Elliott Middleton;Martha Sun

  189
  Citations

• Immunogenicity and Safety of Respiratory Syncytial Virus Subunit Vaccine in Seropositive Children 18-36 Months Old

  D. A. Tristram;R. C. Welliver;C. K. Mohar;D. A. Hogerman

  184
  Citations

• Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion.

  Meissner Hc;Welliver Rc;Chartrand Sa;Law Bj

  180
  Citations

• Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children.

  Robert C. Welliver;Paul A. Checchia;Jay H. Bauman;Ancilla W. Fernandes

  177
  Citations

• Unique epidemiology of nosocomial infection in a children's hospital.

  Robert C. Welliver;Sylvia McLaughlin

  175
  Citations